405 related articles for article (PubMed ID: 38254683)
1. Harnessing Nanotechnology: Emerging Strategies for Multiple Myeloma Therapy.
Yang M; Chen Y; Zhu L; You L; Tong H; Meng H; Sheng J; Jin J
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254683
[TBL] [Abstract][Full Text] [Related]
2. Nano-drug delivery system targeting tumor microenvironment: A prospective strategy for melanoma treatment.
Xu M; Li S
Cancer Lett; 2023 Oct; 574():216397. PubMed ID: 37730105
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle delivery systems, general approaches, and their implementation in multiple myeloma.
de la Puente P; Azab AK
Eur J Haematol; 2017 Jun; 98(6):529-541. PubMed ID: 28208215
[TBL] [Abstract][Full Text] [Related]
4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
5. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
Chung C
Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
[TBL] [Abstract][Full Text] [Related]
7. Nano-Immune-Engineering Approaches to Advance Cancer Immunotherapy: Lessons from Ultra-pH-Sensitive Nanoparticles.
Li S; Bennett ZT; Sumer BD; Gao J
Acc Chem Res; 2020 Nov; 53(11):2546-2557. PubMed ID: 33063517
[TBL] [Abstract][Full Text] [Related]
8. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
9. Nanoscale artificial antigen presenting cells for cancer immunotherapy.
Rhodes KR; Green JJ
Mol Immunol; 2018 Jun; 98():13-18. PubMed ID: 29525074
[TBL] [Abstract][Full Text] [Related]
10. Emerging concepts in designing next-generation multifunctional nanomedicine for cancer treatment.
Chakraborty K; Tripathi A; Mishra S; Mallick AM; Roy RS
Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35638450
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic strategies to enhance immune response induced by multiple myeloma cells.
Liu Z; Yang C; Liu X; Xu X; Zhao X; Fu R
Front Immunol; 2023; 14():1169541. PubMed ID: 37275861
[TBL] [Abstract][Full Text] [Related]
12. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
[TBL] [Abstract][Full Text] [Related]
13. Advances in nano-immunotherapy for hematological malignancies.
Xu J; Liu W; Fan F; Zhang B; Sun C; Hu Y
Exp Hematol Oncol; 2024 May; 13(1):57. PubMed ID: 38796455
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival.
Urbanova M; Cihova M; Buocikova V; Slopovsky J; Dubovan P; Pindak D; Tomas M; García-Bermejo L; Rodríguez-Garrote M; Earl J; Kohl Y; Kataki A; Dusinska M; Sainz B; Smolkova B; Gabelova A
Biomed Pharmacother; 2023 Sep; 165():115179. PubMed ID: 37481927
[TBL] [Abstract][Full Text] [Related]
15. Promising Nanomedicines of Shikonin for Cancer Therapy.
Yan C; Li Q; Sun Q; Yang L; Liu X; Zhao Y; Shi M; Li X; Luo K
Int J Nanomedicine; 2023; 18():1195-1218. PubMed ID: 36926681
[TBL] [Abstract][Full Text] [Related]
16. Nano-drug delivery system: a promising approach against breast cancer.
Malik JA; Ansari JA; Ahmed S; Khan A; Ahemad N; Anwar S
Ther Deliv; 2023 May; 14(5):357-381. PubMed ID: 37431741
[TBL] [Abstract][Full Text] [Related]
17. Instigation of the epoch of nanovaccines in cancer immunotherapy.
Shah S; Famta P; Tiwari V; Kotha AK; Kashikar R; Chougule MB; Chung YH; Steinmetz NF; Uddin M; Singh SB; Srivastava S
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(3):e1870. PubMed ID: 36410742
[TBL] [Abstract][Full Text] [Related]
18. Bridging cancer biology and the patients' needs with nanotechnology-based approaches.
Fonseca NA; Gregório AC; Valério-Fernandes A; Simões S; Moreira JN
Cancer Treat Rev; 2014 Jun; 40(5):626-35. PubMed ID: 24613464
[TBL] [Abstract][Full Text] [Related]
19. Nanotechnology-based immunotherapies to combat cancer metastasis.
Zhao Y; Bilal M; Qindeel M; Khan MI; Dhama K; Iqbal HMN
Mol Biol Rep; 2021 Sep; 48(9):6563-6580. PubMed ID: 34424444
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial prospects of nano-targeted chemoimmunotherapy.
Da Silva CG; Rueda F; Löwik CW; Ossendorp F; Cruz LJ
Biomaterials; 2016 Mar; 83():308-20. PubMed ID: 26796043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
